CD300E and acute myeloid leukemia: According to analysis with the viSNE algorithm, the CD300e (IREM2) marker showed increased expression on t(8;21) AML blasts, and the CD14 and CD35 markers showed decreased expression on the leukemic blasts from the AML inv(16) group, compared to the normal myHPCs in the nodes with statistically significant increased numbers of events in AML cases.